BioCentury
ARTICLE | Company News

Neuropathic pain company Quartet ending operations

November 17, 2017 11:42 PM UTC

In a blog post, former Chairman of Quartet Medicine Inc. (Cambridge, Mass.) Bruce Booth said the biotech is winding down its operations.

According to the post, Quartet found "some concerning and unexpected neurologic effects in the last few days of treatment in the GLP 28-day toxicology study" for one of its lead programs...